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ABSTRACT
Camel trypanosomosis (surra), caused by Trypanosoma evansi, is the most important single cause of 
morbidity and mortality in camels. The disease, transmitted non-cyclically by other haematophagus flies (e.g. 
Tabanus) is endemic in Africa, Asia and South America, and in addition to camels other species of domesticated 
livestock are affected. Because of the wide geographic range of surra, its control has attracted international 
attention, with a focus on formulating and implementing effective strategies aimed at increasing productivity 
and achieving a decrease in mortality and morbidity. In this review, the clinico-pathological effects of surra are 
presented, as their understanding may help in the design of effective control. Anaemia appears to be a major 
component of the pathology of surra. Its development and persistence in the course of the disease induce anoxic 
conditions which manifest signs of dysfunction in various organs as a result of a fall in tissue pH and vascular 
damage. This is followed by the release of large quantities of cytoplasmic and mitochondrial enzymes, especially 
aspartate alanine transferase (AST) and alanine transferase (ALT), among others, into serum, causing further 
cellular and tissue damage. The net effect associated with the above changes is immunosuppression which later 
develops and predisposes the animals to other infections and death if untreated. Therefore, emphasis is placed 
on accurate diagnosis of surra, treatment with effective trypanocidal drugs such as trypan and the use of vector 
control methods in the control and management of this disease.
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Introduction
The camel is the most efficient domesticated animal for converting fodder into work, 
transport, milk and meat.
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Camel trypanosomosis, also known as surra, is a disease of camels caused by 
Trypanosoma evansi. The disease is the most important single cause of economic losses 
in camel rearing areas, causing morbidity of up to 30.0% and mortality of around 3.0% 
(NGERENWA et al., 1993; EGBE-NWIYI and CHAUDRY, 1994; PACHOLEK et al., 2001; NJIRU 
et al., 2002).The causative agent, Trypanosoma evansi, was discovered by Griffith Evans 
in 1880 in infected camels and equids in the Dara Ismail Khan district of Punjab (EVANS, 
cited by INDRAKAMHANG, 1998). Since then, studies have shown that the parasite can infect 
all species of domesticated livestock, although the principle host varies geographically 
(INDRAKAMHANG, 1998; EL-SAWALHY and SEED, 1999; AL-RAWASHDEH et al., 2000).
In Africa, beyond the northernmost limits of the tsetse fly belt, and in parts of East 
Africa, camels are the most important host (DIA et al., 1997), whilst in Central and South 
America the horse is principally affected (MONZON et al., 1990, SILVA et al., 1995). In Asia, a 
much wider range of hosts is involved, including the Bactrian camel and dromedaries, cattle, 
buffalo, horses and pigs (PATHAK et al., 1993; PARTOUTOMO et al., 1994; TUNTASUVAN 
et al., 1996; EL-SAWALHY and SEED, 1999; AL-RAWASHDEH et al., 2000; PACHOLEK et al., 
2001). This is contrary to observations in Africa and South America, where there is little 
evidence to suggest that domesticated livestock other than camels and horses, respectively, 
are clinically affected or infected with Trypanosoma evansi. Nevertheless, there are reports 
of serological evidence of infection in goats and sheep from the Sudan and in cattle from 
Brazil (BOID et al., 1981; FRANKE et al., 1994; LUCKINS, 1998) and both goats and cattle 
have been considered as potential reservoirs of infection (DENNING, 1989; LUCKINS, 
1998). In Nigeria, camels are found in the northern part of the country, most commonly 
in Borno, Kano, Katsina, Kebbi, Sokoto, Jigawa and Yobe states, where they are utilized 
considerably as sources of meat. Most of the camels found in these areas are traded from 
the neighbouring Niger and Chad Republics (OCHAPPA, 1988).
Natural and experimental camel trypanosomosis have been described in different 
parts of the world (DIA et al., 1997; AL-RAWASHDEH et al., 2000; PACHOLEK et al., 2001; 
NJIRU et al., 2002). Severe outbreaks, which occurred in different parts of the world where 
several thousand animals died in the 1970s and, of late, in 1994 and 1995, for instance, 
in Pantamal, Brazil, have also been well documented (LUCKINS, 1998).These epidemics 
pose a major constraint to camel productivity given their importance as a source of meat, 
milk production, transportation and draught power, as well as by-products (wool, hair, 
skin and hides). In addition, they also provide foreign currency to their owners from their 
export (ELAMIN et al., 1999). 
Because of the range of agro-ecological zones and the diverse farming systems in 
which the disease occurs, as well as its debilitating effects on a variety of livestock, surra 
has attracted international attention in recent years, with the hosting of an international 
symposium on strategies for research and control of surra held 19-22 August, 1998, at 
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Obihiro University, Japan, (OBIHIRO, 1998). The symposium was timely, given the recent 
epidemics. Therefore, formulating and implementing strategies for effective control of surra 
as expected will result in decreased production costs, increased productivity, as well as a 
decrease in morbidity and mortality due to the disease.
In this review we will attempt to summarize the present state of our knowledge based 
on available literature, as well as drawing attention to gaps in our knowledge of camel 
trypanosomosis.
Etiology
Trypanosoma evansi is a species belonging to the subgenus Trypanozoon and is the 
causative agent of camel trypanosomosis. It is hypothesized that Trypanosoma evansi 
originated from Trypanosoma brucei by adaptation to a non cyclical mode of transmission 
and loss of ability to undergo growth and differentiation in the fly vector (LUCKINS, 
1998). Camels that came into contact with tsetse flies acquired infections, and when such 
camels moved to non-tsetse areas, transmission was spread by other haematophagous flies. 
Other species of trypanosomes, e.g. Trypanosoma congolense, Trypanosoma brucei and 
Trypanosoma vivax have also been isolated from camels in Sudan, but their role in camel 
trypanosomosis is insignificant (MAHMOUD and GRAY, 1980; ELAMIN et al., 1999).
The disease was further disseminated by camel caravans travelling to North Africa, the 
Middle East and further east into South Asia. In a similar manner, horses were probably 
the means by which surra reached America, principally by movement of the animals from 
West Africa in the 16th century. Evidence from isoenzyme studies and characterization of 
nuclear and kinetoplast DNA support this hypothesis and suggest only a limited evolutionary 
origin of Trypanosoma evansi (GIBSON et al., 1983; SONGA et al., 1990). The most notable 
molecular difference is that while the kinetoplast DNA (KDNA) of Trypanosoma evansi 
lacks maxicircle DNAs and possess only interlocked 1-kb minicircle DNAs, the KDNA 
networks of Trypanosoma brucei has both.
In addition to the name surra, other names such as ‘murrina’, ‘mal de caderas’ 
or ‘derrengadera’ are used to describe similar diseases caused by trypanosomes 
indistinguishable from Trypanosoma evansi in South America. The collective name 
American surra has since been proposed for adoption in South America due to the need to 
maintain uniformity in nomenclature (LOSOS, 1980; LUCKINS, 1998).
The vector
Trypanosoma evansi lacks the genes necessary for mitochondrial development 
(GIBSON et al., 1983; BORST et al., 1987; SONGA et al., 1990) and is therefore unable to 
undergo growth and differentiation in the insect vector. Nevertheless, this has not precluded 
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transmission by insects. It is speculated that the widespread occurrence of Trypanosoma 
evansi is largely due to its being spread mechanically by the bites of haematophagous 
flies, e.g. Tabanus. Stable flies (Stomoxys) have also been incriminated, but based on 
experimental transmission between horses, guinea pigs and dogs, they do not appear to 
be important vectors (LOSOS, 1980).
More than 20 different species of Tabanus have been shown experimentally to 
transmit Trypanosoma evansi (LUCKINS, 1998). Furthermore, surveys of Tabanus in the 
various tropical areas have shown a definite correlation between the seasonal outbreaks 
of Trypanosoma evansi infections and the increase in number of Tabanus during the rains 
(MAHMOUD and GRAY, 1980; NJIRU et al., 2002). Thus, rainfall, suitable moisture-retaining 
clay soil and surface water pools also support the development of suitable camel browsing 
conditions, where Acacia senegal shrubs grow in abundance. The prevalence of some 
Tabanus spp. all year round ensures that transmission of the parasite occurs wherever 
reservoir hosts, vectors and susceptible hosts co-exist. This finding may explain the sporadic 
occurrence of the disease during the dry season and outbreaks during the rainy season (NJIRU 
et al., 2002). However, the efficiency of the different flies to transmit Trypanosoma evansi 
appears to vary in different geographic conditions and is also dependent on the interval 
between two successive feeds and intensity of the fly challenge (LUCKINS, 1998). 
Although the mode of mechanical transmission is well established, its dynamics are 
not understood. Therefore, considerable experimentation is still required to attempt to 
define quantitatively the effect of the host species, the duration of infection in the host and 
the level of parasitaemia, the period between feeds and the relative efficiency of different 
vector species in ensuring successful transmission (OBIHIRO, 1998).
Transmission by biting flies is not the sole means by which infection is perpetuated; 
ingestion of meat from infected carcasses by carnivores can result in infections, and in 
South America, vampire bats are said to be of importance both as reservoirs of infection and 
as vectors (LUCKINS, 1998). However, there no definitive study has ever been conducted 
to confirm their role in the epidemiology of trypanosomosis, and it is therefore not really 
clear how important they are.
Surra distribution 
Surra is widespread in different parts of the world and poses a major constraint to 
camel productivity (ELAMIN et al., 1999). Available information on the prevalence of surra 
caused by Trypanosoma evansi in many countries of the world as reported, are: Nigeria 
(27%), Chad (30%) (LOSOS, 1980); Mauritania (24%) (DIA et al., 1997); Niger (29%) 
(PACHOLEK et al., 2001); Kenya (28%) (NJIRU et al., 2001); Ethiopia (21%) (ZELEKE and 
BEKELE, 2001); Jordan (33%) (AL-RAWASHDEH et al., 2000); India (22%) (PATHAK et 
al., 1999); Sudan (33%) (ELAMIN et al., 1999); Iran (10%) (ZARIF-FARD and HASHEMI-
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FESHARKI, 2001), and South America (27% in carrier state in capybras) (FRANKE et al., 
1994), 35.4 and 43.3%, respectively, in the Tafilalet and Ouarzazate provinces of Morocco 
(RAMI et al., 2003).
Clinical manifestations
Trypanosoma evansi can infect a variety of hosts and causes a species-specific 
pathology. The following descriptions are taken from the accounts of MAHMOUD and 
GRAY (1980) and LUCKINS (1998). In camels the disease is manifested by elevation of 
body temperature which is directly associated with parasitaemia. Infected animals show 
progressive anaemia, marked depression, dullness, loss of condition, and often rapid death. 
Anaemia was observed to be a major clinical finding in camel trypanosomosis in Morocco 
(RAMI et al., 2003). Milder cases develop recurrent episodes of fever. Some camels develop 
oedema in their dependent parts of the body, urticaria plaques and petechial haemorrhages 
in serous membranes. Death finally ensues if untreated. However, some may harbour 
trypanosomes for 2-3 years thus constituting reservoirs of infection to susceptible camels 
and hosts. Other well documented field reports are death (TUNTASUVAN et al., 1997); 
abortion (LOHR et al., 1986); weight loss, reduced draught power (LUCKINS, 1998) and 
nervous signs like circling movement and trembling, unusual aggressiveness, running 
aimlessly and sudden collapse in severely stressed and over worked animals (MANUEL, 
1998). At post mortem, necrotic foci in the liver and spleen as well as generalised lymphoid 
tissue hyperplaisia are common in camels suffering from surra (ROTTCHER et al., 1987).
Pathology and pathogenesis
Anaemia is a major component of the pathology of surra and of African trypanosomosis 
generally. Anaemia in Trypanosoma evansi infections of camels is reportedly macrocytic 
and hypochromic (JATKAR and PUROHIT, 1971). In the early phases of infection the anaemia 
is haemolytic and haemophagocytic. The mechanism(s) responsible for this increased 
erythrophagocytic activity are not fully understood. Several have been proposed, viz, 
immune complexes, expanded mononuclear phagocytic system per se, haemolytic factor 
produced by the trypanosome, fever and disseminated intravascular coagulation (Food 
Agricultural Organization, 1979). In the late stages, anaemia continues to be a major 
factor, with probably additional causes. However, irrespective of the cause of anaemia 
the primary abnormality of function are the anoxic conditions created by the persistent 
anaemia. Following this are signs of dysfunction which appear in the various organs. An 
increase in cardiac output due to increases in stroke volume and heart rate and a decrease 
in circulation time are obvious manifestations. The central nervous system is reported to be 
most susceptible to anoxia with consequent development of cerebral anoxia. The marked 
depression observed in camel trypanosomosis is a mental state and is a manifestation of 
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depression of cerebral cortical function in various degrees. Other nervous signs reported, 
such as circling movement, incoordination and dullness, appear to be the results of brain 
tissue disturbance or damage by the parasites. Evidence of Trypanosoma evansi being 
found in the cerebrospinal fluid has been presented (ROTTCHER et al., 1987).
Tissue damage
The atypical lesions of multiple necrotic foci found in the liver and spleen, as well as 
generalized lymphoid tissue hyperplasia in camels suffering from surra on post mortem, 
could be attributed to pathological events that occur in the tissues of animals infected with 
Trypanosoma evansi. The degenerative changes thus observed could be due to tissue anoxia, 
possibly caused by anaemia, which results in a fall in tissue pH and vascular damage. Other 
mechanisms may also be involved. 
It is known that Trypanosoma evansi is a member of the Brucei group of trypanosomes, 
which have a known preference for connective tissues of a host, where they disrupt the 
collagen bundles and destroy the fibroblasts which produce and maintain the collagen 
(BOID, 1980).This disruption of host connective tissues, along with the vascular damage 
attributable to brucei group trypanosomes (BOID, 1980), would be expected to release 
large quantities of cytoplasmic and mitochondrial enzymes into the serum, thereby causing 
further tissue damage.
Indeed, a two-step process in the pathology of infection with Trypanosoma evansi in 
camels based on studies of changes in serum enzymes has been proposed (BOID, 1980). 
The first step coincides with the appearance of trypanosomes in the host bloodstream 
and is characterized by a sharp and as yet unexplained rise in sorbitol dehydrogenase 
(SDH) activity. The second step occurs later in the infection and is characterized by a 
large increase in serum levels of glutamic oxaloacetic transaminase (GOT) now known as 
aspartate alanine transferase (AST) (DE LA RUE et al., 1997) and a smaller rise in glutamic 
pyruvic transaminase (GPT), now known as alanine amine transferase (ALT) (DE LA RUE 
et al., 1997). The rise in AST level can be attributed partly to cellular damage caused by 
the trypanosomes lysis, while the increase in ALT probably results from host destruction 
of trypanosomes. AST is found mostly in cell organelles and rises when there is a great 
damage to the heart, kidney, skeletal muscles and liver. ALT is a specific liver enzyme 
found in the cell cytoplasm and its rise is associated with cell membrane damage. The 
reported increases in these enzymes, especially AST, is not surprising as it is indicative of 
organ damage and supports the post mortem reports of necrotic foci in the liver and spleen 
of camels suffering from surra.
The fever characterized by high temperature might be due to the effects of toxic 
metabolites produced by dying trypanosomes (TIZARD et al., 1978). In addition, the 
oedema reported in the dependant parts of the body during the chronic stage could be due 
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to a significant decrease in the albumin levels, resulting in alterations in osmotic pressure 
of the blood. This leads to excessive accumulation of fluid in tissue spaces caused by a 
disturbance in the mechanism of fluid interchange between capillaries, the tissue spaces 
and the lymphatic vessels. All this possibly indicates great liver damage (DE LA RUE et al., 
1997). The haemorrhage and serous exudates that occurred could be caused by haemolysis 
involving the expanded mononuclear phagocytic system. This has also been observed 
in Trypanosoma brucei-infected donkeys, while the frequent abortions reported may be 
attributed to endocrine dysfunction (LOSOS, 1980).
Immune response
Pronounced immune changes occur in African trypanosomosis. An increase in 
gamma-globulin (IgM) during both acute and chronic Trypanosoma evansi infections in 
camels has been reported (BOID et al., 1981) but this is not protective, as the majority of 
the antibodies are auto antibodies. Leucocytosis, neutrophilia and eosnophilia have been 
reported in Trypanosoma evansi infections of camels (ANOSA, 1988). These changes 
occur as a result of an increase in the activity of the mononuclear phagocytic system. The 
eosinophilia observed is a feature of parasitic infections and is associated with immediate-
type hypersensitivity reactions. The cells are expected to accumulate in tissue in response 
to tissue injury. In the acute phase of the disease, lymph nodes and spleen are remarkably 
reactive, with plasma cells predominating. This may account for the generalized lymphoid 
tissue hyperplasia characteristic of Trypanosoma evansi infections, while in the late stages 
the immune system becomes depleted of lymphoid cells (LOSOS, 1980).
Circulating and tissue-mediated immune complexes have been demonstrated in 
laboratory animals infected with Trypanosoma brucei species, and much of the antibody 
found in them is directed against the trypanosome (Food Agricultural Organisation, 1979). 
Complement has also been found in association with them. These immune complexes are 
likely to have wide varying pathological effects including anaemia, complement activation, 
tissue damage and interference with both induction and effector mechanisms of the immune 
response (Food Agricultural Organisation, 1979). 
Hypocomplementaemia (decreased alteration of the complement system) has been 
reported, including elevated levels of immunoconglutinin and deposition of complement in 
the tissues. Further possible evidence of complement reactivity is found in the demonstration 
that the kinin system becomes activated with the release of pharmacologically active 
substances, thus causing microvascular dilatation and increased permeability (Food 
Agricultural Organisation, 1979).
A state of immunosuppression later develops associated with these changes. The 
host immune response to a variety of antigens has been found depressed in animals 
under experimental conditions (BALTZ et al., 1981; ANENE et al., 1989; ENWEZOR and 
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EKEJINDU, 1998). Several hypotheses have been put forward to explain trypanosome-
induced immunosuppression, and the most favoured appeared to be the action of 
trypanosome enzymes. Trypanosome enzymes, such as phospholipases (TIZARD et al., 1978), 
neuraminidases (ESIEVO, 1983) and proteases (LONSDALE-ECCLES and GRAB, 1986) have 
all been implicated in membrane fluidity and cellular damage. Moreover, the phospholipases 
generate free fatty acids (FFAs) and these have been reported to not only have a haemolytic 
effect, thus contributing to anaemia, but also to control lymphocyte reactivity through 
their role as prostagladin precursors. The net effect of immunosuppression is lack of pre-
immunity to other diseases. Little wonder then that in most cases secondary infections, e.g. 
bacteria bronchopneumonia, often sets in and death may ensue if untreated.
Diagnosis
There are no pathognomonic signs of surra and so laboratory diagnosis has to be 
carried out to confirm infection. Traditionally, this involves parasitological and serological 
diagnosis. Parasitological diagnosis is mainly carried out by the direct microscopic 
examination of blood or buffy coats and/or sub-inoculation of camel blood into rodents 
such as mice or rats. However, the test has a poor sensitivity, often less than 50% (MONZON, 
1990; NANTULYA et al., 1989; NANTULYA, 1990; LUCKINS, 1992; YADVENDRA et al., 1998). 
The implication of this is that in most situations Trypanosoma evansi is under-diagnosed 
and the level of infection is greater than frequently reported. On the other hand, serological 
techniques, e.g. immunfluorescent antibody test (IFAT), enzyme Linked Immunosorbent 
Assay (ELISA) and the Card Agglutination Test for Trypanosomosis (CATT), although 
sensitive, cannot distinguish current from cured infections (LUCKINS, 1988). 
Recent tests, e.g. latex agglutination test (LAT) or Surratex based on trypanosome- 
antigen detection in blood or serum, are more reliable and have shown a high correlation 
with patent or sub-patent disease in camels (OLAHO-MUKANI et al., 1996). A comparative 
sensitivity test for T. evansi in camels in Kenya revealed 68.8% sensitivity for CATT / 
T. evansi and 58.8% for SURATEX, although the two techniques showed no significant 
difference (NGAIRA et al., 2003). Similarly, at prevalence values between 10 and 100%, 
CATT / T. evansi, as well as SURATEX, had infinitely high positive predictive values, 
whereas SURATES had a lower NPV than CATT / T. evansi and the two techniques were 
more sensitive than parasitological methods in revealing the true extent of trypanosomosis 
in camel herds (NGAIRA et al., 2003). Similarly, ATARHOUCH et al. (2003) diagnosed a 
prevalence of 14.1% via CATT and 18.2% via ab-ELISA in provinces located in the South 
and East of the Atlas mountain chain in Morocco. Also, DELAFASSE and DOUTOUIN (2004) 
using Buffy coat Technique (BCT) and CATT revealed a prevalence rate of T. evansi of 5.3 
and 30.5%, respectively, in Chad. However, non-validation, standardization, application 
and deployment are factors militating against their use in the field.
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Treatment, prevention and control
Treatment with trypanocidal drugs is the usual method of control of Trypanosoma 
evansi and quinapyramine has been used in camels, and only recently melarsomine 
(cymelarsen) (Rhone Merieux, France) was introduced for the treatment of surra in 
camels because of the problem of drug resistance (LUCKINS, 1998; BOURDICHON, 1998). 
Treatment of T. evansi infected camels in Morocco with melarsomine (Cymelarsan (R). 
Rhonemerieux) reduced the sero prevalence level from 58 to 19% within a year (RAMI 
et al., 2003) Resistance up to 500 ng/ml has been found in camels against quinapyramine 
sulphate (BOURDICHON, 1998). Cymelarsen is also effective against T. evansi infections 
in cattle and horses (RAYNAUD et al., 1989) and animals with surra are commonly treated 
at different stages of the disease. However, relapses in camels after treatment have been 
reported (OTSYULA et al., 1992).
Another drug, Trypan, which is a formulation containing diminazene-di-aceturate 
(diamidinophenyltriazene diaceturate tetrahydrate), phenazone and procaine hydrochloride 
is effective against T. evansi infections, as well as infections with Trypanosoma Congolese, 
Trypanosoma vivax, and Trypanosoma brucei. The drug is also effective against Babesia 
bigemina, Babesia canis or other Babesia and Theileria annulata (BOURDICHON, 1998). 
It has a synergistic and an additive effect in comparison with other trypanocidal drugs and 
is reported to have a painless, antipyretic and long-lasting effect. It has also been adjudged 
as being the most effective trypanocidal drug to date (BOURDICHON, 1998). 
With regard to prevention, it has been confirmed that a single injection of 15 ml of 
Trypan affords an animal protection against a new re-infestation over a period of three 
months (BOURDICHON, 1998). Trypan can be used for curative and preventive treatment. 
On the whole, control of surra requires treatment of infected animals with effective drugs 
and reducing blood sucking flies by regular insecticide treatment.
Conclusion
Camel trypanosomosis is a disease of major economic importance in many countries 
in Africa, Asia and South America. The devastating epidemics caused by the disease 
several years back is not frequently seen nowadays, but they do still occur. Although camel 
trypanosomosis has been recognized as the most important single cause of economic losses 
in camel rearing areas, yet there have been no planned campaigns to control T. evansi 
using modern methods of fly control or chemotherapy (LUCKINS, 1998). In most cases, 
control is limited to treating those animals that are considered to be infected on the basis 
of unreliable clinical signs.
Therefore, a number of research issues need to be considered:
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1. Application of validated, standardized diagnostic tests (particularly penside tests) at 
both local and regional levels
2.  Identification of the principal vector species responsible for transmission in different  
ecological situations  
3. Improving understanding of the dynamics of mechanical transmission in endemic and  
epidemic situations
4. Investigating the potential for vector control in the management of this disease
5. Determining the efficacy of different trypanocidal drugs and the extent of drug resistance, 
as well as ascertaining the causes of relapses of cymelarsin in the chemotherapy of 
camel trypanosomosis
6. Determining which factors that precipitate epidemic outbreaks of disease
7. Determining the role of wild animals in the epidemiology of camel trypanosomosis. 
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SAŽETAK
Tripanosomoza deva (Surra) uzrokovana vrstom Trypanosoma evansi najvažniji je uzrok pobola i smrtnosti 
deva. Bolest neciklički prenose hematofagni insekti (npr. Tabanus sp.), a endemska je u Africi, Aziji i Južnoj 
Americi. Osim deva ugrožene su i druge vrste domaćih životinja. Zbog velike zemljopisne proširenosti, kontrola 
bolesti privukla je međunarodnu pozornost s težištem na oblikovanju i uvođenju djelotvornih strategija u svrhu 
povećanja proizvodnosti te smanjenja pobola i smrtnosti. U radu su opisani kliničko-patološki nalazi bolesti s 
ciljem njezina djelotvornog suzbijanja. Glavni znak bolesti je anemija. Razvoj i trajanje anemije  tijekom bolesti 
dovodi do anoksije što se očituje znakovima poremećene funkcije različitih organa kao rezultat pada pH u tkivu 
i oštećenja krvnih žila. Zatim slijedi oslobađanje velikih količina citoplazmatskih i mitohondrijskih enzima, 
naročito aspartat aminotransferaze (AST) i alanin aminotransferaze (ALT) u serum, uzrokujući daljnje stanično 
i tkivno oštećenje. Usporedno s ovim promjenama dolazi i do imunosupresije koja povećava osjetljivost životinja 
za druge infekcije i dovodi do smrti ako se ne liječi. Kontrola bolesti temelji se na njezinoj točnoj dijagnozi, 
liječenju djelotvornim tripanocidnim lijekovima kao što je tripan i primjeni metoda suzbijanja vektora.
Ključne riječi: tripanosomoza, surra, Tripanosoma evansi, Tabanus, anoksija, imunosupresija
